Multirradiculopatia aguda: a propósito de 56 casos

Lamenha, José Airton Gondim; Lyro, Abynadá de Siqueira

doi:10.1590/S0004-282X1993000100018

Resumos

O propósito deste estudo é discutir as características clínicas de 56 casos de síndrome de Guillain-Barré, assim como sua frequência e incidência, em período de 9 anos (1982-1991). A análise dos dados permite salientar a discussão de aspectos acerca de três tópicos principais: incidência da síndrome no semi-árido de Alagoas, sexo-idade, fatores de risco entre pessoas vivendo nessa região.

multirradiculopatia aguda; polirradiculoneurite; síndrome de Guillain-Barre; aspectos regionais (Alagoas)

The purpose of this report is to discuss the clinical characteristics, frequency and incidence of 56 cases of the Guillain-Barré syndrome studied during a nine years period (1982-1991). Results are discussed and main topics pointed out are: incidence of the syndrome at the withered part of the State of Alagoas, sex-age, and long-term risk factors for people living in this region.

acute multiradiculoptathy; polyradiculoneuritis; Guillain-Barre syndrome; regional aspects

José Airton Gondim Lamenha^I; Abynadá de Siqueira Lyro^II

^IDisciplina de Neurologia da Escola de Ciencias Médicas de Alagoas: Professor Auxiliar de Ensino

^IIDisciplina de Neurologia da Escola de Ciencias Médicas de Alagoas: Professor Titular

RESUMO

O propósito deste estudo é discutir as características clínicas de 56 casos de síndrome de Guillain-Barré, assim como sua frequência e incidência, em período de 9 anos (1982-1991). A análise dos dados permite salientar a discussão de aspectos acerca de três tópicos principais: incidência da síndrome no semi-árido de Alagoas, sexo-idade, fatores de risco entre pessoas vivendo nessa região.

Palavras-chave: multirradiculopatia aguda, polirradiculoneurite, síndrome de Guillain-Barre, aspectos regionais (Alagoas).

SUMMARY

The purpose of this report is to discuss the clinical characteristics, frequency and incidence of 56 cases of the Guillain-Barré syndrome studied during a nine years period (1982-1991). Results are discussed and main topics pointed out are: incidence of the syndrome at the withered part of the State of Alagoas, sex-age, and long-term risk factors for people living in this region.

Key words: acute multiradiculoptathy, polyradiculoneuritis, Guillain-Barre syndrome, regional aspects.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

Aceite: 31-julho-1992.

Trabalho da Disciplina de Neurologia da Escola de Ciencias Médicas de Alagoas.

Dr. Abynadá de Siqueira Dyro Disciplina de Neurologia, Escola de Ciências Médicas - Avenida Siqueira Campos 2095, Trapiche da Barra - 57010-001 Maceió AL - Brasil.

1. Dyck PJ, Arnason KGM. Chronic inflammatory demyelinating polyradiculoneuropathy. In Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds): Peripheral neuropathy. Philadelphia: Sauders 1984, p 2101-2114.
2. Eiben RM, Gersony WM. Recognition, prognosis and treatment of the Guillain-Barré syndrome. Med Clin N Amer 1963, 47:1294-1306.
3. Fisher M.. An unusual variant of lacute idiopathic polyneuritis with ophthalmoplegia, ataxia and areflexia. N Engl J Med 1956, 255:57-65.
4. Hafler DA, Weiner HL, MS: a CNS and systemic autoimmune disease Immunol Today 1989, 10:104-107.
5. Jenkis RB. Neuropathies and the Guillain-Barré syndrome. Clin Proc Child Hosp (Wash) 1966, 22:306-317.
6. Kennedy RH, Danielson MA, Mulder DW, Kurland LT. Guillain-Barré syndrome: a 42 year epidemiology and clinical study. Mayo Clin Proc 1978, 53:93-99.
7. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 1971, 50:772-780.
9. Loffel NB, Rossi LN, Mumenthaler M, Lutschig J, Ludin HP. The Landry-Guillain-Barré syndrome: complications, prognosis and natural history. J Neurol Sei 1977, 33:71-79.
9. Masucci EF, Kurtzke JF. Diagnostic criteria for the Guillain-Barré syndrome an analysis of 50 cases. J Neurol Sci 1971, 13:483-501.
10. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1978, 100:1617-1630.
11. McFarland HR, Heller GL. Guillain-Barré disease complex: a statement of diagnostic criteria and analysis of 100 cases. Arch Neurol 1966, 14:196-201.
12. Raphael JC, Masson C, Morice V, Brunei D. Les syndromes de Landry-Guillain-Barré: étude des facteurs prognostiques dans 223 cas. Rev Neurol (Paris) 1986, 142:613-624.
13. Rubin LA, Kurm CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin 2 receptors are released by activated human lymphoid cells in vitro. J Immunol 1985, 135:3172-3177.
14. Schoenberger LB, Hurwitz ED, Katona P, Holman RC, Bregman DJ. Guillain-Barré syndrome: its epidemiology and associations with inflenza vaccination. Ann Neurol 1981 (Suppl), 9:31-38.
15. Selmaj K, Plater-Zyberk C, Rockett KA, Maini RN, Alam R, Perkin GD, Clifford Rose F. Multiple sclerosis: increased expression of interleukin 2 receptors on lymphocytes. Neurology 1986, 36:1392-1395.
16. Sun D, Qin Y, Epplen JT, Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988, 332:843-845.
17. Uchiyama T, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and funcionally mature human T cells. J Immunol 1981, 126:1393-1397.

Multirradiculopatia aguda: a propósito de 56 casos

Acute multiradiculopathy: report on 56 cases

Datas de Publicação

Publicação nesta coleção
19 Jan 2011
Data do Fascículo
Mar 1993

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

[1] 1. Dyck PJ, Arnason KGM. Chronic inflammatory demyelinating polyradiculoneuropathy. In Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds): Peripheral neuropathy. Philadelphia: Sauders 1984, p 2101-2114.

[2] 2. Eiben RM, Gersony WM. Recognition, prognosis and treatment of the Guillain-Barré syndrome. Med Clin N Amer 1963, 47:1294-1306.

[3] 3. Fisher M.. An unusual variant of lacute idiopathic polyneuritis with ophthalmoplegia, ataxia and areflexia. N Engl J Med 1956, 255:57-65.

[4] 4. Hafler DA, Weiner HL, MS: a CNS and systemic autoimmune disease Immunol Today 1989, 10:104-107.

[5] 5. Jenkis RB. Neuropathies and the Guillain-Barré syndrome. Clin Proc Child Hosp (Wash) 1966, 22:306-317.

[6] 6. Kennedy RH, Danielson MA, Mulder DW, Kurland LT. Guillain-Barré syndrome: a 42 year epidemiology and clinical study. Mayo Clin Proc 1978, 53:93-99.

[7] 7. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 1971, 50:772-780.

[8] 9. Loffel NB, Rossi LN, Mumenthaler M, Lutschig J, Ludin HP. The Landry-Guillain-Barré syndrome: complications, prognosis and natural history. J Neurol Sei 1977, 33:71-79.

[9] 9. Masucci EF, Kurtzke JF. Diagnostic criteria for the Guillain-Barré syndrome an analysis of 50 cases. J Neurol Sci 1971, 13:483-501.

[10] 10. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1978, 100:1617-1630.

[11] 11. McFarland HR, Heller GL. Guillain-Barré disease complex: a statement of diagnostic criteria and analysis of 100 cases. Arch Neurol 1966, 14:196-201.

[12] 12. Raphael JC, Masson C, Morice V, Brunei D. Les syndromes de Landry-Guillain-Barré: étude des facteurs prognostiques dans 223 cas. Rev Neurol (Paris) 1986, 142:613-624.

[13] 13. Rubin LA, Kurm CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin 2 receptors are released by activated human lymphoid cells in vitro. J Immunol 1985, 135:3172-3177.

[14] 14. Schoenberger LB, Hurwitz ED, Katona P, Holman RC, Bregman DJ. Guillain-Barré syndrome: its epidemiology and associations with inflenza vaccination. Ann Neurol 1981 (Suppl), 9:31-38.

[15] 15. Selmaj K, Plater-Zyberk C, Rockett KA, Maini RN, Alam R, Perkin GD, Clifford Rose F. Multiple sclerosis: increased expression of interleukin 2 receptors on lymphocytes. Neurology 1986, 36:1392-1395.

[16] 16. Sun D, Qin Y, Epplen JT, Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988, 332:843-845.

[17] 17. Uchiyama T, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and funcionally mature human T cells. J Immunol 1981, 126:1393-1397.